Arthur A. Levin, Chief Scientific Officer at Avidity Biosciences, Inc. (RNA), sold 40,300 shares at $27.97 ($1.1M) on 2021-06-25, disclosed to the SEC on 2021-06-28.
Open-market sale of $1.1M RNA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.76 | 100 | $3K | 0.2% |
| 2 | $27.97 | 17,453 | $488K | 43.1% |
| 3 | $27.97 | 17,453 | $488K | 43.1% |
| 4 | $29.14 | 2,647 | $77K | 6.8% |
| 5 | $29.14 | 2,647 | $77K | 6.8% |
| Total | $28.12 avg | 40,300 |
| $1.1M |
| 100% |
| Filing → |
| RNA | SELL | 2025-08-08 | $5.1M | — | Filing → |
| RNA | SELL | 2025-01-23 | $107K | — | Filing → |
| RNA | SELL | 2024-11-20 | $280K | — | Filing → |